ESC Professional Premium Access

PTX3 as a novel inflammatory biomarker in patients with myocarditis

Congress Presentation

About the speaker

Doctor Andrea Villatore

San Raffaele Hospital, Milan (Italy)
1 follower

5 more presentations in this session

Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals

Speaker: Mr M. Lassen (Boston, US)


Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants

Speaker: Doctor E. Kulikowski (Calgary, CA)


No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

Speaker: Doctor M. Radvan (Brno, CZ)


Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic

Speaker: Doctor E. Alfonso Rodriguez (Hospitalet de Llobregat, ES)


The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank

Speaker: Doctor P. Welsh (Glasgow, GB)


Access the full session

Pericardial disease, myocardial disease, COVID-19

Speakers: Doctor A. Villatore, Mr M. Lassen, Doctor E. Kulikowski, Doctor M. Radvan, Doctor E. Alfonso Rodriguez...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb